WO1998047479B1 - Antioxidant and/or antielastase composition based on lupine oil - Google Patents

Antioxidant and/or antielastase composition based on lupine oil

Info

Publication number
WO1998047479B1
WO1998047479B1 PCT/FR1998/000827 FR9800827W WO9847479B1 WO 1998047479 B1 WO1998047479 B1 WO 1998047479B1 FR 9800827 W FR9800827 W FR 9800827W WO 9847479 B1 WO9847479 B1 WO 9847479B1
Authority
WO
WIPO (PCT)
Prior art keywords
use according
composition
oil
lupine
wheat germ
Prior art date
Application number
PCT/FR1998/000827
Other languages
French (fr)
Other versions
WO1998047479A1 (en
Filing date
Publication date
Priority claimed from FR9705067A external-priority patent/FR2762512B1/en
Application filed filed Critical
Priority to US09/202,959 priority Critical patent/US6146616A/en
Priority to EP98922865A priority patent/EP0914090B1/en
Priority to AU75352/98A priority patent/AU7535298A/en
Priority to DE69841706T priority patent/DE69841706D1/en
Priority to JP10545177A priority patent/JP2000514835A/en
Publication of WO1998047479A1 publication Critical patent/WO1998047479A1/en
Publication of WO1998047479B1 publication Critical patent/WO1998047479B1/en

Links

Abstract

The invention concerns an antioxidant and/or antielastase composition containing lupine oil or one or several fractions thereof, its use in cosmetics, pharmaceutics and as food additive. More particularly it concerns a composition containing a mixture of lupine oil and wheat germ concentrate, preferably in a proportion of 70 wt. % of lupine oil and 38 wt. % of wheat germ concentrate.

Claims

REVENDICATIONS MODIFIEES[reçues par le Bureau international le 6 octobre 1998 (06.10.98); revendications 1-29 remplacées par les revendications 1-28 modifiées (4 pages)] AMENDED CLAIMS [received by the International Bureau on 6 October 1998 (06.10.98); claims 1-29 replaced by modified claims 1-28 (4 pages)]
1. Utilisation de l'huile de lupin ou d'une ou plusieurs de ses fractions pour la réalisation d'une composition anti-oxydante et/ou anti-élastase.1. Use of lupine oil or one or more of its fractions for producing an antioxidant and / or anti-elastase composition.
2. Utilisation selon la revendication 1 caractérisée en ce que ladite huile de lupin est obtenue à partir de farine et/ou de graines de lupin.2. Use according to claim 1 characterized in that said lupine oil is obtained from flour and / or lupine seeds.
3. Utilisation selon la revendication 1 ou 2, caractérisée en ce que ladite huile de lupin est obtenue à partir d'une variété de lupin douce.3. Use according to claim 1 or 2, characterized in that said lupine oil is obtained from a variety of sweet lupine.
4. Utilisation selon la revendication 3, caractérisée en ceque ladite huile de lupin est obtenue à partir de lupinus albus.4. Use according to claim 3, characterized in that said lupine oil is obtained from lupinus albus.
5. Utilisation selon l'une des revendications 1 à 4, caractérisée en ce que ladite fraction est un concentrât d'huile de lupin, obtenu par distillation moléculaire de ladite huile.5. Use according to one of claims 1 to 4, characterized in that said fraction is a lupine oil concentrate, obtained by molecular distillation of said oil.
6. Utilisation selon l'une des revendications 1 ou 5, caractérisée en ce que ladite fraction est une fraction insaponifiable contenue dans un concentrât obtenu par distillation moléculaire de ladite huile.6. Use according to one of claims 1 or 5, characterized in that said fraction is an unsaponifiable fraction contained in a concentrate obtained by molecular distillation of said oil.
7. Utilisation selon la revendication 6, caractérisée en ce que la quantité en poids de la fraction insaponifiable dans le concentrât d'huile de lupin est d'environ 30 % à environ 70 % , de préférence d'environ 45 % environ à 65 % .7. Use according to claim 6, characterized in that the amount by weight of the unsaponifiable fraction in the lupine oil concentrate is from about 30% to about 70%, preferably from about 45% to 65% .
8. Utilisation selon l'une des revendications 1 à 7, caractérisée en ce que ladite composition contient une fraction d'huile de lupin comprenant des dérivés phénoliques. 388. Use according to one of claims 1 to 7, characterized in that said composition contains a fraction of lupine oil comprising phenolic derivatives. 38
9. Utilisation de dérivés polyphé'noliques extraits de l'huile de lupin pour la réalisation d'une composition anti-oxydante et/ou anti-élastase.9. Derivative Using polyphé 'noliques extracted from lupine oil for the production of an anti-oxidant composition and / or anti-elastase.
10. Utilisation selon l'une des revendications 8 ou 9, caractérisée en ce que la teneur en dérivés phénoliques est au moins égale à 20ppm.10. Use according to one of claims 8 or 9, characterized in that the content of phenolic derivatives is at least 20ppm.
11. Utilisation selon l'une des revendications 1 à 10, caractérisée en ce que ladite composition contient de l' huile de germe de blé ou une ou plusieurs fractions de celle-ci.11. Use according to one of claims 1 to 10, characterized in that said composition contains wheat germ oil or one or more fractions thereof.
12. Utilisation selon la revendication 11, caractérisée en ce que ladite fraction d'huile de germe de blé est un concentrât obtenu par distillation moléculaire de ladite huile.12. Use according to claim 11, characterized in that said wheat germ oil fraction is a concentrate obtained by molecular distillation of said oil.
13. Utilisation selon la revendication 12, caractérisée en ce que ladite fraction d' huile de germe de blé est une fraction insaponifiable contenue dans un concentrât obtenu par distillation moléculaire de ladite huile.13. Use according to claim 12, characterized in that said fraction of wheat germ oil is an unsaponifiable fraction contained in a concentrate obtained by molecular distillation of said oil.
14. Utilisation selon la revendication 11 ou 12, caractérisée en ce que ladite composition contient un concentrât d'huile de germe de blé en mélange avec de l'huile de lupin.14. Use according to claim 11 or 12, characterized in that said composition contains a wheat germ oil concentrate in mixture with lupine oil.
15. Utilisation selon la revendication 14, caractérisée en ce que les quantités en poids de concentrât d'huile de germe de blé et d'huile de lupin varient respectivement entre environ 10 % à environ 90 %, et entre environ 90 % à environ 10 %, de manière à ce que le total des quantités de ces deux huiles fasse 100 %. 3915. Use according to claim 14, characterized in that the amounts by weight of wheat germ oil concentrate and lupine oil respectively vary between about 10% to about 90%, and between about 90% to about 10%. %, so that the total amounts of these two oils are 100%. 39
16. Utilisation selon la revendication 15, caractérisée en ce que les quantités en poids de concentrât d'huile de germe de blé et d'huile de lupin sont respectivement de 30 % et de 70 %.16. Use according to claim 15, characterized in that the amounts by weight of wheat germ oil concentrate and lupine oil are respectively 30% and 70%.
17. Utilisation selon l'une des revendications 1 à 16, caractérisée en ce que la composition est une composition cosmétique, notamment comme agent anti-oxydant, anti- radicalaire, anti-élastase, protecteur UVA et/ou UVB, protecteur de l'ADN contre des dommages, notamment oxydatifs.17. Use according to one of claims 1 to 16, characterized in that the composition is a cosmetic composition, especially as an antioxidant, anti-radical agent, anti-elastase, UVA and / or UVB protector, protector of the DNA against damage, including oxidative damage.
18. Utilisation selon l'une des revendications 1 à 16, caractérisée en ce que la composition est une composition pharmaceutique, notamment dermatologique.18. Use according to one of claims 1 to 16, characterized in that the composition is a pharmaceutical composition, especially dermatological.
19. Utilisation selon l'une des revendications 1 à 16 caractérisée en ce que la composition est un produit pharmaceutique pour la prévention ou au traitement des effets des UVA et/ou UVB sur la peau aux niveaux épidermique, dermique, cellulaire ou extra-cellulaire.19. Use according to one of claims 1 to 16 characterized in that the composition is a pharmaceutical for the prevention or treatment of the effects of UVA and / or UVB on the skin at the epidermal, dermal, cellular or extracellular levels. .
20. Utilisation selon l'une des revendications 1 à 16 caractérisée en que la composition est un produit pharmaceutique pour la prévention et le traitement des effets de l'oxydation, de l'élastase et des radicaux libres sur la peau.20. Use according to one of claims 1 to 16 characterized in that the composition is a pharmaceutical for the prevention and treatment of the effects of oxidation, elastase and free radicals on the skin.
21. Utilisation selon l'une des revendications 1 à 16 caractérisée en ce que la composition est un agent ayant une activité de protection de l'ADN contre des dommages notamment oxydatifs.21. Use according to one of claims 1 to 16 characterized in that the composition is an agent having an activity for protecting the DNA against damage including oxidative.
22. Utilisation selon l'une des revendications 1 à 16, caractérisée en ce que la composition est une composition cosmétique ou pharmaceutique et qu'elle comprend une association avec un véhicule physiologiquement acceptable. 4022. Use according to one of claims 1 to 16, characterized in that the composition is a cosmetic or pharmaceutical composition and that it comprises an association with a physiologically acceptable vehicle. 40
23. Utilisation selon la revendication 22, caractérisée en ce que la composition est utilisée en tant que produit solaire protecteur des UVB et/ou A et/ou rayonnement infra-rouge, crème restructurante, raffermissante, produit, notamment crème pour la prévention et la régression des vergetures, crème nutritive, antiride (lutte contre le vieillissement de la peau épider e et derme) et protectrice de jour, contour des lèvres et des yeux, sticks labiaux régénérants et protecteurs.23. Use according to claim 22, characterized in that the composition is used as a sun protection product for UVB and / or A and / or infra-red radiation, restructuring cream, firming product, especially cream for the prevention and control of the skin. regression of stretch marks, nutritive cream, anti-wrinkle (fight against skin aging epidermis and dermis) and protective day, contour of the lips and eyes, lip sticks regenerating and protective.
24. Utilisation selon la revendication 22 ou 23, caractérisée en ce que la composition est formulée pour l'usage topique, notamment sous forme de crème, d'émulsion, de pommade, de stick ou de gel.24. Use according to claim 22 or 23, characterized in that the composition is formulated for topical use, especially in the form of cream, emulsion, ointment, stick or gel.
25. Utilisation selon l'une des revendications 22 à 24, caractérisée en ce que la teneur totale en poids en huile de lupin ou les fractions et huile de germe de blé ou ses fractions de ladite composition est de l'ordre de environ 0.5 % à environ 10 %, de préférence de environ 1% à environ 5%25. Use according to one of claims 22 to 24, characterized in that the total weight content of lupine oil or fractions and wheat germ oil or its fractions of said composition is of the order of about 0.5% at about 10%, preferably from about 1% to about 5%
26. Méthode de traitement cosmétique, caractérisés en ce qu'elle comprend l'utilisation d'une composition selon l'une des revendications 1 à 16 ou 22 à 25 sur la surface cutanée d'un individu.26. Cosmetic treatment method, characterized in that it comprises the use of a composition according to one of claims 1 to 16 or 22 to 25 on the cutaneous surface of an individual.
27. Utilisation d'une composition selon l'une des revendications 1 à 16 à titre de complément alimentaire.27. Use of a composition according to one of claims 1 to 16 as a dietary supplement.
28. Procédé de préparation d'une composition utilisable selon l'une des revendications 12 à 16, caractérisé en ce qu'on prépare un concentrât d' huile de germe de blé par distillation moléculaire et on le mélange à de l'huile de lupin. 28. Process for the preparation of a composition usable according to one of claims 12 to 16, characterized in that a wheat germ oil concentrate is prepared by molecular distillation and is mixed with lupine oil. .
PCT/FR1998/000827 1997-04-24 1998-04-24 Antioxidant and/or antielastase composition based on lupine oil WO1998047479A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/202,959 US6146616A (en) 1997-04-24 1998-04-24 Antioxidant and/or antielastase composition based on lupine oil
EP98922865A EP0914090B1 (en) 1997-04-24 1998-04-24 Antioxidant and/or antielastase dermatological composition based on lupine oil
AU75352/98A AU7535298A (en) 1997-04-24 1998-04-24 Antioxidant and/or antielastase composition based on lupine oil
DE69841706T DE69841706D1 (en) 1997-04-24 1998-04-24 DERMATOLOGICAL ANTIOXIDANT AND / OR ANTIESTASTASE COMPOSITION BASED ON LUPINE OIL
JP10545177A JP2000514835A (en) 1997-04-24 1998-04-24 Antioxidant and / or antielastase compositions based on lupine oil

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705067A FR2762512B1 (en) 1997-04-24 1997-04-24 LUPINE OIL COMPOSITIONS, ESPECIALLY BASED ON LUPINE OIL AND WHEAT GERM OIL AND THEIR USE IN COSMETOLOGY, PHARMACY AND AS A FOOD SUPPLEMENT
FR97/05067 1997-04-24

Publications (2)

Publication Number Publication Date
WO1998047479A1 WO1998047479A1 (en) 1998-10-29
WO1998047479B1 true WO1998047479B1 (en) 1998-11-26

Family

ID=9506268

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1998/000827 WO1998047479A1 (en) 1997-04-24 1998-04-24 Antioxidant and/or antielastase composition based on lupine oil

Country Status (9)

Country Link
US (1) US6146616A (en)
EP (2) EP2225957A1 (en)
JP (1) JP2000514835A (en)
AU (1) AU7535298A (en)
CA (1) CA2258800A1 (en)
DE (1) DE69841706D1 (en)
ES (1) ES2347505T3 (en)
FR (1) FR2762512B1 (en)
WO (1) WO1998047479A1 (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342255B1 (en) * 1998-09-15 2002-01-29 Codex V S.R.L. Topical pharmaceutical compositions useful for the treatment of cutaneous of circulatory pathologies on inflammatory, immune, proliferative of degenerative basis
FR2786696B1 (en) * 1998-12-03 2001-01-26 Silab Sa ACTIVE INGREDIENT WITH DEPIGMENTING POTENTIAL, COSMETIC COMPOSITION USING THE ACTIVE INGREDIENT AND METHOD FOR MONITORING MELANOGENESIS
FR2787714B1 (en) * 1998-12-23 2003-01-31 Pharmascience Lab USE OF UNSAPONIFIABLE VEGETABLE OILS FOR THE PREPARATION OF A MEDICAMENT STIMULATING THE EXPRESSION OF TGF-BETA OR THE EXPRESSION OF THE PAI-1 INHIBITOR OF THE PLASMINOGEN ACTIVATOR
FR2792202B1 (en) 1999-04-19 2003-06-13 Pharmascience Lab LUPINE PEPTIDE EXTRACT AND PHARMACEUTICAL OR COSMETIC OR NUTRACEUTICAL COMPOSITION COMPRISING SUCH EXTRACT
GB9918028D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
FR2798591B1 (en) 1999-09-22 2001-10-26 Pharmascience Lab USE OF A VEGETABLE OIL PRODUCT FOR INCREASING THE SYNTHESIS OF SKIN LIPIDS IN COSMETICS, PHARMACY OR DERMATOLOGY AND AS A FOOD ADDITIVE
US7955611B2 (en) * 2000-01-03 2011-06-07 International Flora Technologies Ltd. Binding and rinse-off of quaternary ammonium compounds for cosmetic and personal care applications
US20090191243A9 (en) * 2000-01-03 2009-07-30 Hill John C High unsaponifiables and methods of using the same and its derivatives and uses thereof
US8529970B2 (en) 2000-01-03 2013-09-10 International Flora Technologies, Ltd. High unsaponifiables and methods of using the same
FR2803598B1 (en) * 2000-01-12 2002-04-26 Pharmascience Lab PROCESS FOR EXTRACTING INSAPONIFIABLE FROM VEGETABLE OILS USING CHLORO-1-BUTANE, COMPOSITION COMPRISING SUCH UNSAPONIFIABLE
FR2806260B1 (en) * 2000-03-20 2005-04-08 Pharmascience Lab USE OF A CONCENTRATED VEGETABLE OIL IN ITS UNPAINSIBLE FRACTION AS A FOOD INGREDIENT, PROCESS FOR THE PREPARATION OF SAID OIL, COMPOSITION OR FOOD SUPPLEMENT CONTAINING THE SAME
FR2822821B1 (en) * 2001-04-03 2004-05-07 Pharmascience Lab LUPINE SEED HULL EXTRACT CONTAINING LUPEOL, ESPECIALLY EXTRACT RICH IN LUPEOL AND PROCESS FOR PREPARING THE SAME
DE10223221A1 (en) * 2002-05-24 2003-12-11 Sebapharma Gmbh & Co Kg Cosmetic composition with a skin-swelling effect
FR2857596B1 (en) * 2003-07-18 2006-02-03 Expanscience Lab USE OF A COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A LUPEOL-RICH EXTRACT AS AN ACTIVE INGREDIENT TO STIMULATE THE SYNTHESIS OF STRESS PROTEINS
FR2857825B1 (en) * 2003-07-25 2005-09-30 Ct Valorisation Ind Agro Resso PROCESS FOR EXTRACTING OIL OF OLEOPROTEAGINOUS OILS, IN PARTICULAR LUPINE SEEDS AND EXTRACT OBTAINED
US7293047B2 (en) * 2003-10-23 2007-11-06 Microsoft Corporation Synchronization view
US7481845B2 (en) * 2004-01-29 2009-01-27 L'oreal Composition for protecting keratin material, process of making, uses thereof
FR2865646B1 (en) * 2004-01-29 2009-02-13 Oreal PROCESS FOR THE PREPARATION OF A COMPOSITION FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS FROM PRESSURIZED FLUID AND PROTECTIVE AGENTS
FR2865642A1 (en) * 2004-01-29 2005-08-05 Oreal PROCESS FOR THE PREPARATION OF A COSMETIC TREATMENT COMPOSITION FROM PRESSURIZED FLUID, CERAMIDES, WAXES AND / OR SILICONES
US20050169876A1 (en) * 2004-01-29 2005-08-04 L'oreal Composition for treating keratin material, process of making, uses thereof
FR2865645B1 (en) * 2004-01-29 2007-10-19 Oreal PROCESS FOR THE PREPARATION OF A COMPOSITION FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS FROM PRESSURIZED FLUID AND VITAMINS
FR2865637B1 (en) * 2004-01-29 2007-10-05 Oreal PROCESS FOR THE PREPARATION OF A COMPOSITION FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS FROM PRESSURIZED FLUID AND COSMETICALLY ACTIVE PARTICLE-PITTED COMPOUNDS
EP1731357A4 (en) * 2004-02-02 2009-03-04 Daihatsu Motor Co Ltd Automobile seat
US9089576B2 (en) * 2004-04-30 2015-07-28 Laboratoires Expanscience Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
FR2869541B1 (en) 2004-04-30 2007-12-28 Expanscience Sa Lab USE OF A COMPOSITION COMPRISING D-MANNOHEPTULOSE AND / OR PERSEITOL FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH A CHANGE IN INITIATED IMMUNITY
FR2869543B1 (en) * 2004-04-30 2006-07-28 Expanscience Laboratoires Sa MEDICAMENT COMPRISING A PEPTIDE AVOCADO EXTRACT FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH A DEFICIENCY OF THE IMMUNE SYSTEM
FR2873295B1 (en) * 2004-07-26 2006-12-01 Expanscience Sa Lab USE OF AT LEAST ONE CONJUGATED FATTY ACID TRIENE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF INFLAMMATION
US20060159645A1 (en) * 2004-10-04 2006-07-20 Jonathan Miller Method of providing lubricious surfaces
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
FR2886849A1 (en) * 2005-09-23 2006-12-15 Chanel Parfums Beaute Soc Par Fractionating a vegetable matter, useful to prevent and/or treat skin disorders, comprises molecular distillation
FR2893252B1 (en) * 2005-11-17 2008-02-15 Engelhard Lyon Sa VEGETABLE EXTRACTS STIMULATING HAS2
FR2910815B1 (en) 2006-12-28 2010-10-29 Expanscience Lab COMPOSITION COMPRISING AN EXTRACT OF QUINOA SEEDS
FR2921836B1 (en) * 2007-10-05 2013-01-18 Limousine D Applic Biolog Ditesilab Soc Ind USE OF AN ACTIVE INGREDIENT COMBINING ACTIVE PRINCIPLES FROM MEDICAGO SATIVA AND LUPINUS ALBUS TO FIGHT POCKETS IN THE EYES
US20090155337A1 (en) * 2007-11-12 2009-06-18 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
JP2011513220A (en) * 2008-02-21 2011-04-28 ヴァトリックス・メディカル・インコーポレーテッド Treatment of aneurysms by application of connective tissue stabilizer in combination with delivery vehicle
FR2938193B1 (en) 2008-11-07 2011-08-12 Expanscience Lab MEDICAMENT OR DERMATOLOGICAL COMPOSITION COMPRISING A PEPTIDE AVOCADO EXTRACT FOR THE TREATMENT AND PREVENTION OF PRUPIT
EP2184052B1 (en) * 2008-11-11 2017-09-20 Kao Germany GmbH Composition for hair
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
FR2948566B1 (en) 2009-07-30 2012-08-10 Expanscience Lab EXTRACT OF SCHIZANDRA SPHENANTHERA FRUIT AND COSMETIC, DERMATOLOGICAL AND NUTRACEUTICAL COMPOSITIONS COMPRISING SAME
FR2948565B1 (en) 2009-07-30 2011-10-28 Expanscience Lab COSMETIC COMPOSITION FOR THE TREATMENT OF ACNE COMPRISING A PETIDIC EXTRACT FROM SCHIZANDRA
FR2949044B1 (en) 2009-08-12 2021-05-07 Expanscience Lab COMPOSITION INCLUDING A FRACTION OF THE UNSAPONIFIABLE
US20110218517A1 (en) * 2009-10-09 2011-09-08 Ogle Matthew F In vivo chemical stabilization of vulnerable plaque
FR2951736B1 (en) * 2009-10-23 2011-12-30 Valagro Carbone Renouvelable Poitou Charentes PROCESS FOR EXTRACTING THE INSAPONIFIABLE FROM RENEWABLE RAW MATERIALS
FR2953135B1 (en) 2009-11-30 2012-05-11 Expanscience Lab MACROSTACHYA ACACIA SEED EXTRACT AND COSMETIC, PHARMACEUTICAL, DERMATOLOGICAL, NUTRACEUTICAL OR FOOD COMPOSITIONS COMPRISING THE SAME
FR2953136B1 (en) 2009-11-30 2012-05-11 Expanscience Lab EXTRACT OF VIGNA UNGUICULATA SEEDS AND COSMETIC, PHARMACEUTICAL, DERMATOLOGICAL, NUTRACEUTICAL OR FOOD COMPOSITIONS COMPRISING THE SAME
FR2953722B1 (en) 2009-12-16 2012-03-09 Expanscience Lab COMPOSITION COMPRISING AT LEAST ONE C7 SUGAR FOR THE TREATMENT OF ALOPECIA, FOR THE COSMETIC TREATMENT OF PHANES, AND FOR THE CARE OF HAIR, CILES OR NAILS
FR2955782B1 (en) 2010-01-29 2014-02-14 Expanscience Lab SOLID / LIQUID EXTRACTION
FR2955784B1 (en) 2010-01-29 2014-02-14 Expanscience Lab LIQUID / LIQUID EXTRACTION
AU2011315525B2 (en) 2010-10-12 2016-05-12 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Antimicrobial protein
FR2969496B1 (en) 2010-12-22 2013-11-08 Expanscience Lab EXTRACT OF PULP AND / OR AVOCADO SKIN RICH IN POLYPHENOLS AND COSMETIC, DERMATOLOGICAL AND NUTRACEUTICAL COMPOSITIONS COMPRISING SAME
FR2969495B1 (en) 2010-12-22 2013-10-11 Expanscience Lab EXTRACT OF MACA-RICH AERIAL PARTS OF POLYPHENOLS AND COMPOSITION COMPRISING THE SAME
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
FR2975004B1 (en) 2011-05-13 2013-06-28 Expanscience Lab NEW ANTI-REDNESS ACTIVE INGREDIENTS AND COSMETIC COMPOSITIONS COMPRISING THE SAME
JP2014516695A (en) 2011-05-18 2014-07-17 バトリックス・メディカル・インコーポレイテッド Coated balloon for vascular stabilization
FR2978452B1 (en) 2011-07-28 2015-01-30 Expanscience Lab LIQUID / LIQUID EXTRACTION WITH A SOLVENT COMPRISING AT LEAST 5 CARBON ATOMS AND 1 OR 2 ATOMS OF OXYGEN
FR2978451B1 (en) * 2011-07-28 2015-01-30 Expanscience Lab SOLID / LIQUID EXTRACTION WITH A SOLVENT COMPRISING AT LEAST 5 CARBON ATOMS AND 1 OR 2 ATOMS OF OXYGEN
US8642665B2 (en) 2011-12-16 2014-02-04 Conopco, Inc. Environmentally friendly, low whitening compositions
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
FR3001889B1 (en) 2013-02-11 2021-02-12 Expanscience Lab USE OF A COMPOSITION CONTAINING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS.
FR3011008B1 (en) 2013-09-24 2017-12-29 Expanscience Lab METHODS OF EVALUATING DELETER EFFECTS OF UV ON CHILD'S SKIN
FR3010906B1 (en) 2013-09-25 2016-12-23 Expanscience Lab LIPID EXTRACT OF PASSIFLOWER SEEDS
FR3016373B1 (en) 2014-01-10 2018-01-19 Laboratoires Expanscience MAMMELON SKIN MODEL RECONSTITUTES
FR3028764B1 (en) 2014-11-26 2016-12-09 Expanscience Lab PEPTIDE AND OSIDIC FRUIT EXTRACT OF SCHIZANDRA AND IMPROVEMENT OF THE NEUROSENSORY SKIN SYSTEM RESPONSE
FR3098405B1 (en) 2019-07-12 2021-06-25 Expanscience Lab Composition comprising passionflower seed polyphenols, avocado peptides and witch hazel extract and use to treat and / or prevent stretch marks

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2155727C3 (en) * 1971-11-10 1982-06-16 Hoechst Ag, 6000 Frankfurt Process for the isomerization of unsaturated fatty acid esters of polyhydric alcohols
DE3329249A1 (en) * 1983-08-12 1985-02-21 Skw Trostberg Ag, 8223 Trostberg METHOD FOR EXTRACTION OF FORMABLE FLOWABLE MEASURES
FR2618332B1 (en) * 1987-07-23 1990-04-27 Synthelabo LIPID EMULSION FOR PARENTERAL OR ENTERAL NUTRITION
FR2657539B1 (en) * 1990-01-29 1992-04-03 Commissariat Energie Atomique PROCESS FOR EXTRACTING THE CONSTITUENTS OF A PLANT MATERIAL USING SELECTIVE SOLVENTS.
FR2692783B1 (en) * 1992-06-25 1995-05-05 Expanchimie Compositions based on unsaponifiable fractions of wheat germ and sesame oils, and their uses in particular in cosmetology and as a food supplement.

Similar Documents

Publication Publication Date Title
WO1998047479B1 (en) Antioxidant and/or antielastase composition based on lupine oil
FR2474310A1 (en) STABLE SOLUTION WITH OXIDATION OF VITAMIN F AND JOJOBA OIL AND COSMETIC COMPOSITIONS CONTAINING THE SAME
FR2721208A1 (en) Composition for topical use containing an antioxidant and a bacterial extract, and use of this composition.
WO2007144521A2 (en) Cosmetic composition for topical use comprising wasabi
FR2653333A1 (en) PRODUCT BASED ON ALOA LEAF JUICE, PREPARATION METHOD AND APPLICATION.
JP3635081B2 (en) Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, external preparations for skin, cosmetics and foods
KR20100061881A (en) Cosmetic composition for promoting desquamation
JP2000128765A (en) Skin cosmetic
KR101014219B1 (en) Antioxidant, skin preparation for external use, cosmetic and food
WO2010146294A1 (en) Plant extract for preparing a composition for controlling melanogenesis, resulting control composition, and control method implementing such a composition
KR20120021353A (en) Composition of external application for using bamboo sprout
US6340456B1 (en) Use of a flavonoid extract of ginkgo biloba substantially devoid of terpenes, in the dentibuccal field, and composition containing such extract
KR101870377B1 (en) Cosmetic composition for improving moisturizing and antioxidant containing ultrasonicating extract of cucumber seed
EP3801778B1 (en) Use of a bixa orellana extract
KR102009206B1 (en) Cosmetic composition comprising extract of red onion fermented by aureobasidium pullulans
KR20190137327A (en) Skin external application composition for anti-aging
EP0475851B1 (en) Antioxydant system based on basic aminoacid and a tocopherol
KR101086227B1 (en) Cosmetic Composition Comprising the extract of Lloydia triflora Bak as Active Ingredient
KR20090078082A (en) The skin beautifing cosmetic composition containing vitamin c and the extract of opuntia ficus-indica l. var. saboten makino flowers
KR102107193B1 (en) Cosmetic composition comprising extract of calendula arvensis fermented by aureobasidium pullulans
FR3004347A1 (en) COSMETIC COMPOSITION COMPRISING ESSENTIAL OIL OF SAGE AND USE THEREOF
KR102018512B1 (en) Cosmetic composition comprising extract of saliva miltiorrhiza fermented by aureobasidium pullulans
JPH1192332A (en) Skin preparation composition for external use
KR101170166B1 (en) Compositions for Promotion of Collagen synthesis
WO2019077268A1 (en) Cosmetic composition for active prevention of the signs of ageing